Article info
Review
Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
- Correspondence to Prof Sarosh R Irani, Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK;sarosh.irani{at}ndcn.ox.ac.uk
Citation
Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
Publication history
- Received December 26, 2019
- Revised April 16, 2020
- Accepted April 30, 2020
- First published June 28, 2020.
Online issue publication
September 21, 2020
Article Versions
- Previous version (21 September 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.